Fineotex Chemical Limited (FCL) announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. For the fourth quarter of FY 2026, the company reported consolidated revenue from operations of Rs. 313.73 Crores, a significant increase from Rs. 119.79 Crores in the corresponding quarter of the previous year, reflecting a growth of 161.91%. The consolidated Profit After Tax (PAT) for the quarter rose to Rs. 43.80 Crores from Rs. 20.13 Crores in the same period last year, marking a growth of 117.56%.

Fineotex Chemical Limited is a leading multinational specialty chemical company headquartered in Mumbai, India. Founded in 1979 by Mr. Surendra Tibrewala, the company manufactures and supplies over 450 specialty chemicals and enzymes, catering to diverse industries such as textiles, home care, hygiene, mining, and oil & gas. With state-of-the-art manufacturing facilities in India, Malaysia, and the United States, the company serves customers in over 70 countries. FCL is recognized as a “Great Place to Work” and has achieved multiple international certifications, including ZDHC, GOTS, and NABL, underscoring its commitment to innovation, sustainability, and operational excellence. The company’s growth is driven by a strategic, asset-light, and R&D-focused business model, including key acquisitions like Biotex (Malaysia) and CrudeChem Technologies (USA), which have significantly expanded its global reach and technical capabilities. In 2025, the company continued to strengthen its market position, including the board’s approval of an equity share split and a bonus share issuance in a 4:1 ratio. Notable shareholders in the company include Nippon India Small Cap Fund and prominent investor Ashish Kacholia.